CRISPR Therapeutics
Manufacturing · Switzerland · 201-500 Employees
View Company Info for Free
Overview
Headquarters
Baarerstrasse 14, Zug, Zug, 6300, Switze...Phone Number
+41 415613277Website
www.crisprtx.comRevenue
<$5 MillionStock Symbol
CRSPIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
4
1
1
1
1
About CRISPR Therapeutics
Crispr Therapeutics, founded in 2013 and headquartered in Zug, Switzerland, is a developer of gene-based medications that target diseases at the molecular level.Explore more
CRISPR Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CRISPR Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if CRISPR Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if CRISPR Therapeutics is spiking on competitors!
Click to see if CRISPR Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at CRISPR Therapeutics
CRISPR Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when CRISPR Therapeutics launches new products
Funding: Get notified immidiatlly once CRISPR Therapeutics has new funding data
Earning: See what the market has to say on CRISPR Therapeutics recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
CRISPR Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
CRISPR Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about CRISPR Therapeutics.
CRISPR Therapeutics financials insights
Gather financial insights about CRISPR Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Stock Offering
$56M
CRISPR Therapeutics Tech Stack
A closer look at the technologies used by CRISPR Therapeutics
See more technologies
Most Recent Scoops
Open Position
Open Position
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Hiring Plans
Hiring Plans
CRISPR Therapeutics News & Media
CRISPR Therapeutics AG (CRSP) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
CRISPR Therapeutics AG (CRSP) Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 9, 2026 2:40 PM EDTCompany ParticipantsRaju Prasad - Chief...CRISPR Therapeutics Has $2.4 Billion in Cash and an Approved Drug. Why Is Its Stock Trading Nearly 40% Below the Wall Street Consensus?
The company seems to be doing everything it's supposed to be doing; the stock just isn't responding.CRISPR Therapeutics AG (CRSP): One of The most Shorted Mid Cap Stocks to Buy on Robust Gene Editing Pipeline
CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the most shorted mid-cap and small-cap stocks to buy now. On May 27, research firm Citizens reiterated a Market Perform rating and a $60 price target on CRISPR Therapeutics AG (NASDAQ:CRSP). The stance comes on the heels of the company maintaining a positive view of in vivo editing […]CRISPR Therapeutics AG (CRSP) Presents at 46th Annual William Blair Growth Stock Conference Transcript
CRISPR Therapeutics AG (CRSP) 46th Annual William Blair Growth Stock Conference June 3, 2026 5:40 PM EDTCompany ParticipantsRaju Prasad - Chief Financial...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CRISPR Therapeutics
Sign Up For FreeTo access detailed company insights
Crispr Therapeutics, founded in 2013 and headquartered in Zug, Switzerland, is a developer of gene-based medications that target diseases at the molecular level.... Read More
